American Journal of Clinical Dermatology

Article	Citations
Rosacea: New Concepts in Classification and Treatment	114
Sunscreens and Photoaging: A Review of Current Literature	114
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review	113
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	106
Psychosocial Effects of Vitiligo: A Systematic Literature Review	103
Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments	87
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program	79
Erythema Nodosum: A Practical Approach and Diagnostic Algorithm	78
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study	78
Ceramides in Skin Health and Disease: An Update	72
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis	71
Clinical Course and Characteristics of Generalized Pustular Psoriasis	66
Pathophysiology of Generalized Pustular Psoriasis	66
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review	65
Dermatitis Herpetiformis: An Update on Diagnosis and Management	62
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis	54
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)	54
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options	51
The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses	51
New Practical Aspects of Sweet Syndrome	50
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study	48
Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies	46
Deucravacitinib for the Treatment of Psoriatic Disease	40
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	40
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	40

50 Years of Topical Retinoids for Acne: Evolution of Treatment	39
Teledermatology During COVID-19: An Updated Review	38
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma	36
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis	35
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial	35
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice	35
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey	35
Clinical Disease Measures in Generalized Pustular Psoriasis	35
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study	33
The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World	33
Investigational Treatments for Epidermolysis Bullosa	33
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials	33
Diagnosis of Generalized Pustular Psoriasis	31
The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation	31
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outco	30
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review	30
Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies	28
Behçet Disease: An Update for Dermatologists	27
Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions	27
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System	27
New Topical Therapies for Psoriasis	26
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis	25
HLA-Cw1 and Psoriasis	25
A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis	25
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety	25
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma	25
Oral Lichen Planus: An Update on Diagnosis and Management	24
Syphilis in Dermatology: Recognition and Management	24
Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment	24
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey	23
A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions	23
What’s New in Topicals for Atopic Dermatitis?	23
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020	22
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics	21
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination	20
Cutaneous Manifestations of SARS-CoV-2 Infection	20
Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study	20
Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors	19
The Use of Lasers and Light Devices in Acne Management: An Update	19
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial	19
Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma	19
Photoprotection for Skin of Color	19
The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature	18
Effect of Vitamin D Serum Levels and Supplementation on Atopic Dermatitis: A Systematic Review and Meta-analysis	18
Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management	18
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma	18
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris	18
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020	17
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis	17
Leukonychia: What Can White Nails Tell Us?	17

Pediatric Mastocytosis: Recognition and Management	17
Climate Change, Skin Health, and Dermatologic Disease: A Guide for the Dermatologist	17
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians	17
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	17
Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments	17
Cholinergic Urticaria: Subtype Classification and Clinical Approach	17
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions	16
Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges	16
Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis	16
Tralokinumab for the Treatment of Atopic Dermatitis	16
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	16
Pruritus in Pregnancy	16
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis	15
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity	15
Alopecia Areata: Current Treatments and New Directions	15
Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review	15
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	14
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	14
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	14
Advances in Topical Treatments of Cutaneous Malignancies	14
Skin Cancer in People of Color: A Systematic Review	14
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries	14
Economic Burden of Chronic Hand Eczema: A Review	13
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	13
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons	12
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants	12
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	12
Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide	12
Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study	12
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	12
New Developments in Topical Acne Therapy	12
Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies	12
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	11
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial	11
What’s New in Therapy for Male Androgenetic Alopecia?	11
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	11
Eyebrow and Eyelash Alopecia: A Clinical Review	11
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	11
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	11
Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?	11
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study	11
Eczematous Drug Eruptions	11
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	10
Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene	10
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview	10
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	10
Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management	10
Targeting Inflammation in Acne: Current Treatments and Future Prospects	10
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	10
Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis	10
Management of Difficult-to-Treat Warts: Traditional and New Approaches	10
Efinaconazole in Onychomycosis	10
Surgical Site Infection After Dermatologic Procedures: Critical Reassessment of Risk Factors and Reappraisal of Rates and Causes	10
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	9
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	9
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial	9
Therapeutic Strategies for Untreated Capillary Malformations of the Head and Neck Region: A Systematic Review and Meta-Analyses	9
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	9
Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009–2022)	9
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome	8
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review	8
Review of Perineural Invasion in Keratinocyte Carcinomas	8
Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series	8
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	8
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial	7
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	7
The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma	7
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature	7
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors	7
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy	7
Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events	7
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	7
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases	7
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	7
Treatment of Hyperhidrosis: An Update	7
Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?	7
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	7
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	7
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	7
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum	6

Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	6
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	6
Early Treatment Initiation Improves Outcomes in Nevus of Ota: A 10-Year Retrospective Study	6
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	6
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?	6
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance	6
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies	6
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	6
Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database	6
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial	6
Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What’s New?	6
Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments	6
Effects of Exercise and Dietary Modifications on Hidradenitis Suppurativa: A Systematic Review	6
Paradoxical Hypertrichosis Associated with Laser and Light Therapy for Hair Removal: A Systematic Review and Meta-analysis	6
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients	6
Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study	6
Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors	6